Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned
Learn More
-
-
The Conference Call on Q3 takes place on November 4, 2025
Learn More -
Living well with diabetes and beyond
Learn More -
Responding to Natural Disasters and Geopolitical Conflicts
Learn More -
Research in brief: Protein loss with high-flux and medium cut-off membranes
Learn More -
Finding purpose and perseverance: A dialysis nurse’s quiet heroism
Learn More
No Results Found
